Dianthus Therapeutics Participates in Five Investor Conferences

• Dianthus Therapeutics will attend Guggenheim’s 3rd Annual Healthcare Innovation Conference on Nov. 9, 2026, with a fireside chat at 11:00 a.m. ET.
• CEO Marino Garcia will participate in a Stifel Healthcare Conference fireside chat on Nov. 11, 2026, at 9:20 a.m. ET.
• Ryan Savitz, EVP, CFO and CBO, will host one-on-one investor meetings at the Truist Securities BioPharma Symposium on Nov. 12, 2026.
• The UBS Global Biopharma Conference appearance includes a fireside chat on Nov. 16, 2026, at 9:20 a.m. GMT.
• A Jefferies Global Healthcare Conference fireside chat is scheduled for Nov. 18, 2026, at 2:30 p.m. GMT.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611021601PRIMZONEFULLFEED9857379) on November 02, 2026, and is solely responsible for the information contained therein.